Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.
In a double-blind, placebo-controlled study, self-administered intranasal human interferon alpha A produced by recombinant DNA technology was given both before and after virus challenge with a respiratory coronavirus. The incidence of colds, the severity of symptoms and signs, and virus replication...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1983
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185930/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6318655/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.5.713 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|